Loading...
Found 607 iu-health-enterprise-system trials
A listing of iu-health-enterprise-system medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
L
Larry Cripe, MD
This study investigates how patients with CLL/SLL make decisions about their treatment options. CLL stands for chronic lymphocytic leukemia, and SLL stands for small lymphocytic lymphoma, both of which are types of blood cancers. The study aims to understand patient perspectives on choosing between different treatments and to gather feedback …
R
Raj Vuppalanchi, MD
Do you have liver damage because of excessive alcohol use? Join our study!Researchers at the Indiana University School of Medicine are looking for adult volunteers to take part in a study looking at the link between heavy drinking and liver disease.Your participation may help researchers to gain knowledge that may …
K
Kathy Miller, MD
This study investigates the financial barriers faced by breast cancer patients who participate in clinical trials. Breast cancer is a disease where cells in the breast grow uncontrollably. This study looks at costs like lost income, travel, and parking for patients enrolled in these trials.Participants will complete a one-time paper …
N
Nabil Adra, MD
This study investigates circulating tumor DNA (ctDNA) in patients with high-risk stage I and clinical stage II germ cell tumors. Circulating tumor DNA is a biomarker that helps show how the body responds to cancer treatments. By collecting blood and tissue samples, researchers aim to see if ctDNA can be …
K
Khushali Jhaveri
This study investigates the effectiveness of two treatments for people with a type of cancer called follicular lymphoma, which affects certain white blood cells. The purpose of this study is to compare an investigational medication with rituximab, which is a monoclonal antibody that attaches to a protein on cancer cells …
T
Tarah Ballinger, MD
This study investigates the effects of an investigational treatment regimen combined with a checkpoint inhibitor on patients with advanced metastatic breast cancer. Metastatic breast cancer is when cancer cells spread from the breast to other parts of the body. The study compares this combination treatment to the usual treatment chosen …
V
Vijaya L. Kakani, MD
We understand that living with non-small cell lung cancer (NSCLC), especially with the KRAS G12C mutation, can be incredibly challenging. Many people with lung cancer go through hard treatments and tough side effects. That's why we're inviting adults (ages 18 and older) who have advanced or metastatic nonsquamous NSCLC to participate …
S
Sharon Moe, MD
What you eat matters when you have chronic kidney disease (CKD)—and researchers want to learn what works best.The IU School of Medicine is studying how diet affects kidney health and invites people with CKD to join a nutrition research contact list. By signing up, you’ll be notified about studies that …
T
Tarah Ballinger, MD
This study investigates the use of an investigational medication to reduce joint pain caused by Aromatase Inhibitor Associated Musculoskeletal Syndrome (AIMSS) in patients with breast cancer. Aromatase inhibitors are drugs used in the treatment of breast cancer, and sometimes they can cause joint pain as a side effect. The purpose …
S
Susan Conroy, MD PhD
This study investigates the effects of an investigational medication on adults with treatment-resistant depression (TRD). TRD is when a person with major depressive disorder (MDD) does not respond to at least two different antidepressant treatments. The purpose of this study is to compare depressive symptoms in participants receiving the investigational …
Please choose between Voice or SMS based delivery of verification code
or